Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001213900-20-001122
Filing Date
2020-01-15
Accepted
2020-01-15 17:05:29
Documents
2

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k0120_aytubioscience.htm 425 30153
2 FIRST AMENDMENT TO MERGER PURCHASE AGREEMENT, DATED JANUARY 9, 2020 f8k0120ex10-1_aytubioscience.htm EX-10.1 216226
  Complete submission text file 0001213900-20-001122.txt   248341
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOSCIENCE, INC (Filed by) CIK: 0001385818 (see all company filings)

IRS No.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOSCIENCE, INC (Subject) CIK: 0001385818 (see all company filings)

IRS No.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 425 | Act: 34 | File No.: 001-38247 | Film No.: 20528807
SIC: 2834 Pharmaceutical Preparations